Comparable company analysis, commonly called comparable-company analysis, trading comparables or a comps analysis, is a market-based valuation method that estimates the value of a business by examining how similar publicly traded companies are valued by investors. Analysts identify an appropriate peer group, calculate valuation multiples for those companies and apply selected multiples to the subject company's financial measures. Common multiples include enterprise value to revenue, enterprise value to EBITDA, enterprise value to EBIT and price to earnings. The method is a relative valuation technique because it does not calculate value directly from the subject company's projected cash flows; instead, it uses observed market valuations of businesses with relevant characteristics as external evidence.
Selecting appropriate comparables is the most important judgement in the analysis. Relevant characteristics can include industry, products, services, business model, geography, customer base, scale, growth, margins, capital intensity, recurring revenue, cyclicality and risk. Broad industry classification alone does not establish genuine comparability. Two software companies can have substantially different valuation characteristics if one operates a high-margin recurring subscription model and another depends on low-margin project work. Analysts therefore typically screen potential peers and document why each selected company is sufficiently comparable. Where no perfect peers exist, the analysis can use a broader group while explicitly recognising the differences and interpreting the resulting multiples cautiously.
The analyst calculates the relevant enterprise or equity value for each comparable company and divides it by an appropriate financial metric. Enterprise-value multiples are generally matched with operating measures such as revenue, EBITDA or EBIT, while equity-value multiples are matched with equity measures such as net income or earnings per share. The numerator and denominator must therefore be conceptually consistent. Analysts may use historical or forward financial measures. Forward multiples can better reflect current investor expectations but depend on analyst or management forecasts. Historical multiples use reported results but may be less representative if the company's current economics differ significantly from historical conditions.
The resulting peer multiples are normally examined as a distribution rather than treated as a single automatic answer. Analysts can consider median, mean, quartiles and observed ranges, while investigating unusually high or low observations. An outlier may result from exceptional growth, temporary earnings conditions, a takeover expectation, unusual leverage or another company-specific factor. Removing an observation should have a methodological justification rather than simply being done because it produces an inconvenient result.
The subject company is then compared with the peer set on growth, profitability, scale and risk. A business with faster growth and stronger margins may reasonably command a different multiple from a slower-growing peer, but the conclusion must be supported by the underlying market evidence and valuation context.
Enterprise value must be converted to equity value when the valuation objective concerns shareholders. If comparable-company analysis indicates an enterprise value of £40 million and the subject company has £10 million of debt and £4 million of surplus cash, a simplified equity value would be £34 million. Other adjustments may be necessary for leases, pension obligations, minority interests, preferred securities, non-operating assets and debt-like liabilities. If the analysis uses a price-to-earnings multiple, the valuation already relates to equity value and should not be converted in the same way. Matching the type of multiple with the corresponding financial metric is therefore a fundamental technical requirement.
Comparable-company analysis provides external market evidence and can be updated relatively quickly as public share prices and financial forecasts change. However, the market valuation of a public company reflects factors that may differ from those affecting a private business, including liquidity, investor access, reporting requirements, scale and market visibility. Private businesses may be smaller, more concentrated in customers or management and less liquid. Analysts therefore need to consider whether the selected public companies genuinely reflect the subject company's risk and economics. The use of size or liquidity adjustments is context-dependent and should not be applied as a mechanical universal rule.
Comparable company analysis differs from precedent transaction analysis because the latter examines actual acquisition transactions rather than ongoing public-market valuations. Transaction multiples can incorporate control, synergies, competitive bidding and transaction-specific circumstances. Trading multiples reflect market prices for publicly traded securities and can change daily. DCF valuation differs again because it derives value primarily from projected cash flows and a discount rate. Asset-based valuation focuses on the economic value of assets and liabilities. These methods can therefore produce different valuation indications without one necessarily being mathematically inconsistent with another. The differences should be analysed in relation to their assumptions and the characteristics of the subject company.
A robust comparable-company analysis documents the peer-selection criteria, valuation date, share-count basis, enterprise-value calculation, financial periods, treatment of exceptional items, forecast sources and selected valuation multiples. Analysts must ensure that financial periods and accounting measures are sufficiently comparable and should investigate acquisitions, disposals, discontinued operations and unusual events that can distort reported figures. The method works particularly well when the subject business operates in an industry with a meaningful population of economically similar public companies. Where comparables are scarce or materially different, the analysis becomes less reliable and should be treated as one piece of valuation evidence alongside DCF, precedent transactions or asset-based methods.
